Association between the leptin gene 2548G/A polymorphism, the plasma leptin and the metabolic syndrome with psoriasis

Experimental Dermatology

Volumn 20, Issue 9, 2011, Pages 715-719

  Abdel Hay, Rania M ^a   Rashed, Laila A ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Gene polymorphism; Leptin; Metabolic syndrome; Psoriasis

Indexed keywords

LEPTIN;

ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREDICTOR VARIABLE; PROTEIN BLOOD LEVEL; PSORIASIS; SINGLE NUCLEOTIDE POLYMORPHISM;

BASE SEQUENCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEPTIN; MALE; METABOLIC SYNDROME X; POLYMORPHISM, SINGLE NUCLEOTIDE; PSORIASIS; RISK FACTORS;

EID: 80051671194     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2011.01299.x     Document Type: Article

References (40)

1. Nestle F O, Kaplan D H, Barker J. N Engl J Med 2009: 361: 496-509.
2. Poeggeler B, Schulz C, Pappolla M A et al. Exp Dermatol 2010: 19: 12-18.
3. Bjørbaek C, Kahn B B. Recent Prog Horm Res 2004: 59: 305-331.
4. Matarese G. Eur Cytokine Netw 2000: 11: 7-14.
5. Hoffstedt J, Eriksson P, Mottagui-Tabar S et al. Horm Metab Res 2002: 34: 355-359.
6. Griffiths C E, Barker J N. Lancet 2007: 370: 263-271.
7. Boehncke W H, Boehncke S, Schön M P. BMJ 2010: 340: b5666.
8. Cerman A A, Bozkurt S, Sav A et al. Br J Dermatol 2008: 159: 820-826.
9. Aktan S, Rita S, Erdogan B S et al. Turk J Med Sci 2007: 37: 135-138.
10. Taylor W, Gladman D, Helliwell P et al. Arthritis Rheum 2006: 54: 2665-2673.
11. Fredriksson T, Pettersson U. Dermatologica 1978: 157: 238-244.
12. Grundy S M, Brewer H B Jr, Cleeman J I et al. Circulation 2004: 109: 433-438.
13. Washko M E, Rice E W. Clin Chem 1961: 7: 542-545.
14. Roeschlau P, Bernt E, Gruber W. Z Klin Chem Klin Biochem 1974: 12: 226-227.
15. Wallace T, Levy J, Matthews D. Diabetes Care 2004: 27: 1487-1495.
16. Iciek R, Wender-Ozegowska E, Seremak-Mrozikiewicz A et al. J Physiol Pharmacol 2008: 59: 19-31.
17. Le Stunff C, Le Bihan C, Schork N J et al. Diabetes 2000: 49: 2196-2200.
18. Ren W, Zhang S H, Wu J et al. Chin Med J 2004: 117: 558-561.
19. Duffin K C, Woodcock J, Krueger G G. Dermatol Ther 2010: 23: 101-113.
20. Kara N, Aydin F, Senturk N et al. Int J Dermatol 2007: 46: 1271-1274.
21. Hinuy H M, Hirata M H, Forti N et al. Arq Bras Endocrinol Metabol 2008: 52: 611-616.
22. Cook P W, Mattox P A, Keeble W W et al. Mol Cell Biol 1991: 11: 2547-2557.
23. Lee S W, Park M C, Park Y B et al. Rheumatol Int 2006: 11: 155-159.
24. Evereklioǧlu C, İnalöz H S, Kirtak N et al. Br J Dermatol 2002: 147: 331-336.
25. Wang Y, Chen J, Zhao Y et al. Br J Dermatol 2008: 158: 1134-1135.
26. Ozdemir M, Okudan N, Gumusel M et al. Turkiye Klinikleri J Dermatol 2006: 16: 98-101.
27. Johnston A, Arnadottir S, Gudjonsson J E et al. Br J Dermatol 2008: 159: 342-350.
28. Naldi L, Chatenoud L, Linder D et al. J Invest Dermatol 2005: 125: 61-67.
29. Gelfand J M, Neimann A L, Shin D B et al. JAMA 2006: 296: 1735-1541.
30. Sterry W, Strober B E, Menter A. Br J Dermatol 2007: 157: 649-655.
31. Sommer D M, Jenisch S, Suchan M et al. Arch Dermatol Res 2006: 298: 321-328.
32. Cohen A D, Sherf M, Vidavsky L et al. Dermatology 2007: 216: 152-155.
33. Gisondi P, Tessari G, Conti A et al. Br J Dermatol 2007: 157: 68-73.
34. Takahashi H, Takahashi I, Honma M et al. J Dermatol Sci 2010: 57: 143-144.
35. Ahmed E L-S F, Seliem M K, El-kamel M F et al. Egypt J Dermatol and Androl 2009: 29: 91-100.
36. Boehncke S, Thaci D, Beschmann H et al. Br J Dermatol 2007: 157: 1249-1251.
37. Fernandez-Real J M, Ricart W. Endocr Rev 2003: 24: 278-301.
38. Gannage'-Yared M H, Khalife S, Semaan M et al. Eur J Endocrinol 2006: 155: 167-176.
39. Hamminga E A, Van Der Lely A J, Neumann H A et al. Med Hypotheses 2006: 67: 768-773.
40. Pearson T A, Blair S N, Daniels S R et al. Circulation 2002: 106: 388-391.